Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danoprevir + Ritonavir + PegIFN/RBV in Asian HCV Genotype 1
NCT01749150Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of danoprevir in chronic hepatitis C (CHC), sponsored by Roche. Started Apr 2013; status: completed.
02
Drugs
danoprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT01749150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749150.